Create an Account
  1. Home
  2. Specialty
  3. General Ophthalmology

What’s Next in Retinal Care? What You Need to Know About Novel Therapies to Optimize Outcomes

ReachMD Healthcare Image
Program Information
Take Pre-Test

Thank you for attending.

Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain at the synchronous in-person symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion. 

To obtain your CE credit:
After verification of attendance, within 48 hours of the program's completion, you will receive an email with a link to take the posttest, complete the evaluation, and claim your credit. 

Thank you for attending. Please proceed to the post-test and evaluation to claim credit. 

Thank you for attending this course. Please click "Next Page" to proceed to the posttest, evaluation, and claim your credit. You will have 2 weeks to claim your credit.

Thank you for attending. Please select "Next Page" to proceed. 

Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain at the synchronous in-person symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion. 

To obtain your CE credit:
After verification of attendance, within 48 hours of the program's completion, you will receive an email with a link to take the posttest, complete the evaluation, and claim your credit. 

Scroll back to top
Details

  • Overview

    This highly dynamic, interactive discussion will focus on optimizing outcomes for patients with neovascular age-related macular degeneration and diabetic eye disease. 

    Dr. Brian K. Do will present data on real-world outcomes, discuss new and emerging therapies, and highlight the ideal patients for these therapies. A series of cases will further enrich the discussion.  

    Note, attendees will be emailed a link to the posttest, evaluation, and credit Thursday, September 29, 2022. 

    This activity is supported by an unrestricted medical education grant from Genentech, a member of the Roche Group.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Summarize the current treatments and barriers to optimizing medical management of patients with diabetic eye diseases and neovascular age-related macular degeneration in clinical settings
    • Discuss future therapies and their implications for patient outcomes
    • Identify patients who may benefit from the next generation of retinal disease therapies

    • Accreditation

      Evolve Medical Education, LLC is a COPE-accredited administrator. 
      This activity, COPE Activity Number 124657, is accredited by COPE for continuing education for optometrists. This course is approved for 1.5 hours CE.
      Course #: 80493-TD
      Activity #: 124657

      COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

      Course Viewing Requirements

      Supported Browsers:
      Internet Explorer 11 for Windows
      Edge (recent versions; Chromium-based) for Windows
      Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Safari (recent versions) for Mac OSX, or iOS

      Hardware Requirements:
      4GB+ RAM
      Recommended internet speed 5Mbps+

       

    • Faculty and Disclosures

      Brian K. Do, MD

      Brian K. Do, MD

      The Retina Group of Washington
      Washington, DC


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Brian K. Do, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan/Abbvie, Alimera Life Sciences, and EyePoint Pharmaceuticals. Speaker’s Bureau: Allergan/Abbvie.

      The Evolve staff, planners, and reviewers have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group. 

       

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    1.50 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free